from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2337c/-

LFCtreatmentdescriptionclass of inhibitor

-0.289

Amikacinug/mL Amikacintranslation

0.230

Cap5-10ug/mL Capreomycintranslation

0.005

Rox10-50 ug/mL Roxithromycintranslation

0.840

SM2-5 ug/mL Streptomycintranslation

0.331

Tet5-10 ug/mL Tetracyclinetranslation

0.954

Rif0.2-5ug/mL Rifampicintranscription

0.589

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.890

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.921

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.016

CPZ10-50 ug/mL Chlorpromazinerespiration

0.395

Clofazimine10-13 ug/mL Clofaziminerespiration

0.267

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.777

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.091

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.930

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.411

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.401

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.077

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.493

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.619

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.091

KCN5-20 ug/mL Potassium cyaniderespiration

1.593

NaN30.2-2 mM Sodium aziderespiration

0.331

Nigericin50 uM Nigericinrespiration

0.425

TRC10-150 ug/mL Triclosanrespiration

-1.224

TRZ10-25 ug/mL Thioridazinerespiration

-1.576

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-2.055

menadione6-10 ug/mL Menadionerespiration

-0.185

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.063

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.798

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.635

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.872

NRP_1Non-replicating persistence stage 1dosRassociated

0.249

Amp0.2mg/mL AmpicillincellWall

-0.174

Cephalexin20-100 ug/mL CephalexincellWall

0.634

Cerulenin0.32-5 ug/mL CerulenincellWall

0.486

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.567

EMB10-20 ug/mL EthambutolcellWall

0.611

Eta12-40 ug/mL EthionamidecellWall

0.399

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.061

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.155

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.484

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.129

BZA0.12 mg/mL BenzamidearomaticAmides

0.439

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.114

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.625

H2O24 mM hydrogen peroxideDNAdamaging

-0.015

Levo10 ug/mL LevofloxacinDNAdamaging

0.238

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.193

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.563

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.368

UVUV-irradiationDNAdamaging

-0.928

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.114

Antimycin12.5-50 ug/mL Antimycin A?

-0.420

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.030

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.707

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.498

PA8240.2-2 ug/mL PA-824?

-0.243

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.347

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.050

Verapamil50 uM Verapamil?

-0.586

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.137

methoxatin10-20 ug/mL Methoxatin?